CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The INDIGO project aims to improve the understanding and treatment of Graves' orbitopathy, a condition affecting the eyes due to autoimmune thyroid disease. It focuses on identifying risk factors, developing early diagnostic methods, and creating safe interventions through advanced research techniques and collaboration…
Graves' orbitopathy (GO), also known as thyroid eye disease, affects approximately 3 million people in Europe with an estimated socioeconomic burden of 6.4 billion euros per annum. GO is a complication of Graves' disease which is an autoimmune disease and the commonest cause of an overactive thyroid gland.
The treatment of GO remains unsatisfactory and the majority of patients report long-term impairment of quality of life.
To improve the outcomes of people with GO and thus reduce long-term illn…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, LODI
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Essen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, PORT TALBOT WEST GLAMORGAN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
